These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23639412)

  • 1. Percutaneous sclerotherapy of sialoceles after parotidectomy with fibrin glue, OK-432, and bleomycin.
    Chen WL; Zhang LP; Huang ZQ; Zhou B
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):786-8. PubMed ID: 23639412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous sclerotherapy of juvenile nasopharyngeal angiofibroma using fibrin glue combined with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Li JS; Chai Q; Zhang DM
    Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):422-5. PubMed ID: 20189660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.
    Chen WL; Huang ZQ; Zhang DM; Chai Q
    Head Neck; 2010 Apr; 32(4):467-72. PubMed ID: 19672870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation.
    Zhao XP; Huang ZQ; Chen WL; Wang YY; Lin ZY
    Br J Oral Maxillofac Surg; 2016 Feb; 54(2):187-91. PubMed ID: 26705860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of superficial parotidectomy versus extracapsular lumpectomy in the treatment of benign parotid lesions.
    Prichard AJ; Barton RP; Narula AA
    J R Coll Surg Edinb; 1992 Jun; 37(3):155-8. PubMed ID: 1328626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subtotal parotidectomy for a parotid gland tumour in two players of wind instruments, with preservation of facial nerve function].
    Heeremans EH; Mastboom WJ
    Ned Tijdschr Geneeskd; 2007 Mar; 151(9):543-7. PubMed ID: 17373397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of epithelial parotid tumours.
    Obaid MA; Yusuf A
    J Coll Physicians Surg Pak; 2004 Jul; 14(7):394-9. PubMed ID: 15279739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.
    Zheng JW
    Head Neck; 2010 Jun; 32(6):826-7; author reply 827. PubMed ID: 20474076
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrograde parotidectomy for pleomorphic adenoma of the parotid gland: a conservative and effective approach.
    Scarpini M; Amore Bonapasta S; Ruperto M; Vestri A; Bononi M; Caporale A
    J Craniofac Surg; 2009 May; 20(3):967-9. PubMed ID: 19461345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial parotidectomy: technical modifications based on tumour characteristics.
    Papadogeorgakis N; Skouteris CA; Mylonas AI; Angelopoulos AP
    J Craniomaxillofac Surg; 2004 Dec; 32(6):350-3. PubMed ID: 15555516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type b for the treatment of a sialocele after parotidectomy.
    Pantel M; Volk GF; Guntinas-Lichius O; Wittekindt C
    Head Neck; 2013 Jan; 35(1):E11-2. PubMed ID: 21688341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Our experience in the treatment of the tumors of parotid gland].
    Rossi Izquierdo M; Frade González C; Cabanas Rodríguez E; Dios Loureiro C; Lozano Ramírez A; Labella Caballero T
    An Otorrinolaringol Ibero Am; 2007; 34(3):257-71. PubMed ID: 17725170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial superficial parotidectomy as the method of choice for treating pleomorphic adenomas of the parotid gland.
    Papadogeorgakis N
    Br J Oral Maxillofac Surg; 2011 Sep; 49(6):447-50. PubMed ID: 20638162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and management of siaolocele after parotidectomy.
    Witt RL
    Otolaryngol Head Neck Surg; 2009 Jun; 140(6):871-4. PubMed ID: 19467406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parotid tumor size predicts proximity to the facial nerve.
    Domenick NA; Johnson JT
    Laryngoscope; 2011 Nov; 121(11):2366-70. PubMed ID: 22020887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracapsular dissection versus superficial parotidectomy in pleomorphic adenomas of the parotid gland.
    Uyar Y; Cağlak F; Keleş B; Yıldırım G; Saltürk Z
    Kulak Burun Bogaz Ihtis Derg; 2011; 21(2):76-9. PubMed ID: 21417969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of parotid neoplasms.
    Dykun RJ; Deitel M; Borowy ZJ; Jackson S
    Can J Surg; 1980 Jan; 23(1):14-9. PubMed ID: 6244883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour recurrence after surgical removal of parotid pleomorphic salivary adenoma using a retrograde facial nerve dissection technique.
    O'Regan B; Bharadwaj G
    Br J Oral Maxillofac Surg; 2012 Jul; 50(5):417-9. PubMed ID: 21880405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign parotid tumour enucleation--a reliable operation in selected cases.
    Comoretto R; Barzan L
    J Laryngol Otol; 1990 Sep; 104(9):706-8. PubMed ID: 2172430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.